Table 3.
Multivariate analyses of prognostic factors for overall survival in young (age <60 years old) whole AML and non-M3 patients
| Whole AML | non-M3 | |||
|---|---|---|---|---|
|
| ||||
| hazard ratio (95% CI) | P value | hazard ratio (95% CI) | P value | |
| WBC | 2.738 (1.137-6.597) | 0.025 | 3.249 (1.178-8.956) | 0.023 |
| Karyotype classifications | 3.845 (1.695-8.724) | 0.001 | 3.835 (1.465-10.041) | 0.006 |
| ID1 expression | 2.114 (0.850-5.259) | 0.107 | 3.012 (1.105-8.213) | 0.031 |
| FLT3 mutation | 0.902 (0.190-4.278) | 0.897 | 1.553 (0.274-8.809) | 0.619 |
| NPM1 mutation | 0.685 (0.089-5.303) | 0.717 | 0.704 (0.084-5.877) | 0.745 |
| C/EBPA mutation | 1.149 (0.334-3.958) | 0.826 | 1.151 (0.319-4.158) | 0.830 |